Disusun oleh:
Axel Jusuf
1461050177
Dosen Pembimbing:
Dr. Josef Siregar, Sp.Rad
KEPANITERAAN RADIOLOGI
PERIODE 5 NOVEMBER – 8 DESEMBER 2018
FAKULTAS KEDOKTERAN UNIVERSITAS KRISTEN INDONESIA
2018
Egypt J Chest Dis Tuberc
67:50–55
© 2018 The Egyptian
Journal of Chest Diseases
and Tuberculosis 2090
PENDAHULUAN Egypt J Chest Dis Tuberc
67:50–55
© 2018 The Egyptian
Journal of Chest Diseases
USG ( Ultrasonography) and Tuberculosis 2090
PATOFISIOLOGI
67:50–55
© 2018 The Egyptian
Journal of Chest Diseases
and Tuberculosis 2090
Sesak nafas
Batuk kering
Mudah lelah
Nyeri dada
Egypt J Chest Dis Tuberc
67:50–55
GAMBARAN RADIOLOGIK
© 2018 The Egyptian
Journal of Chest Diseases
and Tuberculosis 2090
PASIEN
14
Egypt J Chest Dis Tuberc 67:50–55
Alat Pemeriksaan
Spesifikasi Alat:
Philips ultrasound Affiniti 50G, Philips, Germany
3.5-MHz convex probe dan 7.5–10 MHz linear probe
Pemeriksaan :
Setiap pasien diperiksa parunya dengan USG
Thoraks dalam posisi duduk ataupun supine
Pasien diposisikan dengan kedua tangan di taruh
diatas kepala
Setiap hemithorax di bagi jadi 3 zona, total 6 zona
Bila ditemukan minimal 3 B-Lines dalam 1 zona
dianggap zona positif
Bila ditemukan minimal 2 zona positif bilateral,
hasil pemeriksaan dianggap positif
Egypt J Chest Dis Tuberc 67:50–55
© 2018 The Egyptian Journal of Chest
Diseases and Tuberculosis 2090
Pengolahan Data
Data Prospektif
16
Egypt J Chest Dis Tuberc
67:50–55
© 2018 The Egyptian
E. Peningkatan jarak antar B-lines (dalam mm), penebalan pleura, irreguleritas pleura, dan
hilangnya sliding paru normal, menunjukkan keparahan IPF
F. Jarak antara 2 B-lines yang bersebrangan dikorelasikan dengan derajat reticular pattern
pada HRCT.
Egypt J Chest Dis Tuberc 67:50–55
© 2018 The Egyptian Journal of Chest
Diseases and Tuberculosis 2090
Egypt J Chest Dis Tuberc 67:50–55
© 2018 The Egyptian Journal of Chest
Diseases and Tuberculosis 2090
PEMBAHASAN
of Chest Diseases and
Tuberculosis 2090
KESIMPULAN
2 Launay D, Remy-Jardin M, Michon-Pasturel U, Masora L, Hachulla E, Lambert M, et al. High resolution computed tomography in
fibro sing alveolitis associated with systemic sclerosis. J Rheumatol 2006; 33: 1789–1801.
3 Peros-Golubicic T, Sharma Om P. Clinical atlas of interstitial lung disease. London: Springer 2006. p. 10.
4 Strickland B, Strickland N. The value of high definition, narrow section computed tomography in fibro sing alveolitis. Clin
Radiol 1988; 39: 589–594.
5 Koegelenberg CFN, Bolliger CT, Diacon AH. Pleural ultrasound. In: Light RW, Lee YC, editors. Textbook of pleural disease. 2nd
ed. London: Hodder and Stoughton 2008. pp. 275–283.
6 Gargani L. Lung ultrasound: a new tool for the cardiologist. Cardiovasc Ultrasound 2011; 9:6.
8 Soldati G, Copetti R, Sher S. Sonographic interstitial syndrome: the sound of lung water. J Ultrasound Med 2009; 28:163–174.
10 Lichtenstein DA, Mezière GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol.
Chest 2008; 1341:117–125.
11 Koenig SJ, Narasimhan M, Mayo PH. Thoracic ultrasonography for the pulmonary specialist. Chest 2011; 140:1332–1341.
Lichtenstein DA. Should lung ultrasonography be more widely used in the assessment of acute respiratory disease? Expert Rev
Respir Med 2010; 4:533–538.
14 Reissig A, Kroegel C. Transthoracic ultrasound of lung and pleura in the diagnosis of pulmonary embolism: a novel non-invasive
bedside approach. Respiration 2003; 70:441–452.
REFERENSI
15 Tsai TH, Jemg J-S, Yang P-C. Clinical applications of transthoracic ultrasound in chest medicine. J Med Ultrasound 2008; 16:7–25.
16 LevesqueR.SPSSprogramminganddatamanagement.aguideforSPSS and SAS users. 4th ed. Chicago, IL: SPSS Inc; 2007.
17 DouglasWW,RyuJH,SchroederDR.Idiopathicpulmonaryfibrosis:Impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med 2000; 161:1172–
1178.
18 King TE Jr, Tooze JA, Schwarz MI, Brown KR, Chrniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med
2001; 164:1171–1181.
19 Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61:980–985.
20 Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. Brit Med J 1990; 301:1015–1017.
21 ManninoDM,EtzelRA,ParrishRG.PulmonaryfibrosisdeathsintheUnited States, 1979-1991: an analysis of multiple-cause mortality data. Am J Respir Crit Care Med 1996; 153:1548–
1552.
22 Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada S, Hayes J, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir
J 2006; 27:136–142.
24 NadrousHF,MyersJL,DeckerPA,RyuJH.Idiopathicpulmonaryfibrosisin patients younger than 50 years. Mayo Clin Proc 2005; 80:37–40.
25 IwaiK,MoriT,YamadaN,YamaguchiM,HosodaY.Idiopathicpulmonary fibrosis: epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 1994; 150:670–675.
26 Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150:967–972.
27 Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or wood dust and etiology of cryptogenic fibrosing alveolitis. Lancet 1996; 347:284–289.
28 Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, Slifer SH, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005;
172:1146–1152.